SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-19-188474
Filing Date
2019-07-03
Accepted
2019-07-02 20:50:34
Documents
1
Group Members
CRG PARTNERS III (CAYMAN) LEV AIV I L.P.CRG PARTNERS III (CAYMAN) UNLEV AIV I L.P.CRG PARTNERS III - PARALLEL FUND A L.P.CRG PARTNERS III - PARALLEL FUND B (CAYMAN) L.P.CRG PARTNERS III L.P.IROKO PHARMACEUTICALS INCIROKO PROPERTIES INC.LOAN SECURITY HOLDI

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d748219dsc13da.htm SC 13D/A 203538
  Complete submission text file 0001193125-19-188474.txt   205519
Mailing Address 600 LEE ROAD SUITE 100 WAYNE PA 19087
Business Address 600 LEE ROAD SUITE 100 WAYNE PA 19087 610-833-4200
Zyla Life Sciences (Subject) CIK: 0001586105 (see all company filings)

IRS No.: 463575334 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87969 | Film No.: 19939908
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1000 MAIN STREET, SUITE 2500 HOUSTON TX 77002
Business Address 1000 MAIN STREET, SUITE 2500 HOUSTON TX 77002 713-209-7350
Capital Royalty L.P. (Filed by) CIK: 0001702352 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A